Stocks and Investing Stocks and Investing
Wed, March 5, 2025
[ Yesterday Afternoon ] - Politico
Crypto Can't Stop Fighting Itself
[ Yesterday Afternoon ] - MSN
What is a Financial Consultant?
[ Yesterday Afternoon ] - WIBC
The Health Benefits of Doing Push-Ups
[ Yesterday Afternoon ] - Forbes
Blue Yonder: 2024 Business Review

Boom to gloom: India middle-class jitters amid trillion-dollar market rout


Published on 2025-03-05 17:21:11 - BBC
  Print publication without navigation

  • India's benchmark Nifty 50 share index, which tracks the country's top 50 publicly traded companies, is on its longest losing streak in 29 years, declining for five straight months. This is a significant slump in one of the world's fastest-growing markets. Stock brokers are reporting that their activity has dropped by a third.

The article from the BBC discusses the ongoing debate over the use of puberty blockers for transgender youth in the UK. It highlights the recent decision by NHS England to restrict the use of these medications outside of research settings, following a review that raised concerns about the lack of long-term data on their effects. Puberty blockers, which delay the physical changes of puberty, have been a point of contention, with advocates arguing they provide crucial time for young people to explore their gender identity without the pressure of unwanted physical changes. Critics, however, express worries about potential impacts on bone density, brain development, and fertility. The article also touches on the emotional and psychological impact on transgender youth and their families, with some feeling that the decision limits their options for care. The debate encompasses medical ethics, the rights of transgender individuals, and the balance between caution and access to treatment.

Read the Full BBC Article at:
[ https://www.bbc.com/news/articles/cz7vlezv05no ]
Contributing Sources